Requirement for IL-13 independently of IL-4 in experimental asthma

被引:1602
|
作者
Grünig, G
Warnock, M
Wakil, AE
Venkayya, R
Brombacher, F
Rennick, DM
Sheppard, D
Mohrs, M
Donaldson, DD
Locksley, RM
Corry, DB [1 ]
机构
[1] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco, CA 94143 USA
[2] Univ Calif San Francisco, San Francisco Gen Hosp, Dept Lung Biol, San Francisco, CA 94143 USA
[3] Univ Calif San Francisco, Dept Pathol, San Francisco, CA 94143 USA
[4] Calif Pacific Med Ctr, Dept Transplantat, San Francisco, CA 94115 USA
[5] Univ Cape Town, Groote Schuur Hosp, Dept Immunol, ZA-7700 Rondebosch, South Africa
[6] DNAX Res Inst Mol & Cellular Biol Inc, Palo Alto, CA 94304 USA
[7] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94143 USA
[8] Univ Calif San Francisco, Dept Immunol Microbiol, San Francisco, CA 94143 USA
[9] Genet Inst, Cambridge, MA 02140 USA
关键词
D O I
10.1126/science.282.5397.2261
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
The pathogenesis of asthma reflects, in part, the activity of T cell cytokines. Murine models support participation of interleukin-4 (IL-4) and the IL-4 receptor in asthma. Selective neutralization of IL-13, a cytokine related to IL-4 that also binds to the alpha chain of the IL-4 receptor, ameliorated the asthma phenotype, including airway hyperresponsiveness, eosinophil recruitment, and mucus overproduction. Administration of either IL-13 or IL-4 conferred an asthma-like phenotype to nonimmunized T cell-deficient mice by an IL-4 receptor alpha chain-dependent pathway. This pathway may underlie the genetic associations of asthma with both the human 5q31 Locus and the IL-4 receptor.
引用
收藏
页码:2261 / 2263
页数:3
相关论文
共 50 条
  • [1] Requirement for IL-13 independently of IL-4 in experimental asthma
    Grunig, G
    Warnock, M
    Wakil, AE
    Venkayya, R
    Brombacher, F
    Rennick, DM
    Sheppard, D
    Mohrs, M
    Donaldson, DD
    Locksley, RM
    Corry, DB
    FASEB JOURNAL, 1999, 13 (04): : A318 - A318
  • [2] Distinct signal requirement for IL-4 and IL-13 expression
    Keen, JC
    Natarajan, S
    Burke, T
    Guo, J
    Cianferoni, A
    Schmidt, J
    Casolaro, V
    Wills-Karp, M
    Georas, SN
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2001, 107 (02) : S148 - S148
  • [3] Distinct roles for IL-13 and IL-4 via IL-13 receptor α1 and the type II IL-4 receptor in asthma pathogenesis
    Munitz, A.
    Brandt, E. B.
    Mingler, M.
    Finkelmant, F. D.
    Rothenberg, M. E.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2008, 105 (20) : 7240 - 7245
  • [4] Role of periostin, FENO, IL-13, lebrikzumab, other IL-13 antagonist and dual IL-4/IL-13 antagonist in asthma
    Agrawal, Swati
    Townley, Robert G.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2014, 14 (02) : 165 - 181
  • [5] Atopy and asthma: genetic variants of IL-4 and IL-13 signalling
    Shirakawa, T
    Deichmann, KA
    Izuhara, K
    Mao, XQ
    Adra, CN
    Hopkin, JM
    IMMUNOLOGY TODAY, 2000, 21 (02): : 60 - 64
  • [6] Association of the expression of IL-4 and IL-13 genes, IL-4 and IgE serum levels with allergic asthma
    Afshari, Jalil Tavakkol
    Hosseini, Reza Farid
    Farahabadi, Sara Hesseini
    Heydarian, Farhad
    Boskabady, Mohammad Hossein
    Khoshnavaz, Rasoul
    Razavi, Alireza
    Karimiani, Ehsan Ghayoor
    Ghasemi, Gholamreza
    IRANIAN JOURNAL OF ALLERGY ASTHMA AND IMMUNOLOGY, 2007, 6 (02) : 67 - 72
  • [7] Structural similarity of IL-13 and IL-4
    Tang, JCT
    Cannon-Carlson, S
    Varnerin, J
    Tsarbopoulos, A
    Wylie, D
    FASEB JOURNAL, 1997, 11 (09): : A1361 - A1361
  • [8] IL-4/IL-13 axis as therapeutic targets in allergic rhinitis and asthma
    Husna, Siti Muhamad Nur
    Shukri, Norasnieda Md
    Ashari, Noor Suryani Mohd
    Wong, Kah Keng
    PEERJ, 2022, 10
  • [9] Allergy and asthma: What 'drives' IL-4 versus IL-13 signalling?
    Minton, Kirsty
    NATURE REVIEWS IMMUNOLOGY, 2008, 8 (03) : 166+167 - 167
  • [10] Il-4 and IL-13 act independently and synergistically to drive type 2 inflammation
    Le Floc'H, Audrey
    Allinne, Jeanne
    Nagashima, Kirsten
    Scott, George
    Birchard, Dylan
    Asrat, Seblewongel
    Sleeman, Matthew
    Murphy, Andrew
    Orengo, Jamie
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54